BRIEF-Polyrizon Files For U.S. Patent Application To Expand Ip Moat Around Intranasal Drug-Delivery Platform

1

Oct 5 (Reuters) – Polyrizon Ltd: * POLYRIZON FILES FOR U.S. PATENT APPLICATION TO EXPAND IP MOAT AROUND INTRANASAL DRUG-DELIVERY PLATFORM Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)